chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Muscle and joint pain Exhaustion Fever (101) Chills All began by 4 hours post injection and resolved by morning of 2nd day post injection
I went to see the doctors because I had trouble breathing. I was coughing up green stuff. I had a fever the day before I went to the doctor but not on the day I went to the doctor. They gave me 6 pills of Zythromyocin - Z-Pac and they gave me an inhaler with a new booster thing to get it all the way in my lungs. Mucinex prescription as well to make it break up. Within 24 hours, I was feeling better.
lung/coughing issues; Pneumonia; Coughing issues; wheezing; throwing up; This is a spontaneous report from a contactable consumer (patient). A non-pregnant 59-year-old female patient received BNT162B2 via an unspecified route of administration on 19Apr2021 13:15 (at 59-year-old) (Lot Number: EN6207) as dose 2, single in arm left for COVID-19 immunisation. Medical history included thyroid disorder. Concomitant medication included estradiol; levothyroxine sodium (SYNTHROID); lorazepam (ATIVAN); allium sativum bulb/ ascorbic acid/ colecalciferol/ echinacea purpurea whole plant/ piper nigrum fruit/ sambucus nigra fruit/ zinc citrate (IMMUNETI). The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received BNT162B2 via an unspecified route of administration in Apr2020 13:15 (at 59-year-old) (Lot Number: EN6199) as dose 1, single in arm left for COVID-19 immunisation. Prior to vaccination, the patient wasn't diagnosed with COVID-19. On 05May2021, doctor diagnosed with pneumonia given two antibiotics ambutral Nasal PE tabs OTC. On 19Jul2021 chest X ray pneumonia in the right lung another antibiotic. Talked with nurse on 05Aug2021, still having lung/coughing issues (lung issue from 19Jul2021), fluticasone 50 Claritin. Coughing only got worse, to the point of wheezing, throwing up from 02May2021. More first thing in the morning and late evening. The event resulted in doctor or other healthcare professional office/clinic visit. The patient received 3 different antibiotic Nasal PE tabs in total as treatment. The patient tested negative for COVID-19 on 12Aug2021 since vaccination. The outcome of the events was not resolved.
Patient complained of a headache that started on 3-30-21 day after vaccine. On 4-5-21 developed stomach cramping with mucous in stools. Today when presenting to Dr. office she had bloody stool
pt recv vax 3FEB98 & w/in 2hr exp swelling from deltoid to elbow-unable to move arm redness @ site exp 50m fever to 103;
nauseous; her entire body is very itchy; left arm (where the vaccine was administered) became very itchy/entire body; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (left arm (where the vaccine was administered) became very itchy/entire body) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 17-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Sep-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PRURITUS (left arm (where the vaccine was administered) became very itchy/entire body) (seriousness criterion medically significant). On 20-Sep-2021, the patient experienced NAUSEA (nauseous) and PRURITUS (her entire body is very itchy). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Vaccination site pruritus, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PRURITUS (left arm (where the vaccine was administered) became very itchy/entire body), NAUSEA (nauseous) and PRURITUS (her entire body is very itchy) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication information was provided.  It was reported that within 3 minutes after the administration of the vaccine, the patient's left arm (where the vaccine was administered) became very itchy. She was advised by the pharmacist to go tot the emergency room (ER) where she was given Benadryl shot and was advised to continue Benadryl. As of today, her entire body is very itchy and she is still nauseous (started last 20Sep2021).  The patient wants to know if she should proceed with the 2nd dose because her pharmacist told her not to get the 2nd dose while the ER doctor told her to have it.  Company comment: This case concerns a 35-year-old, female patient with no previous relevant medical history, who experienced the unexpected event of vaccination site pruritus. The event occurred on the same day after the first dose of mRNA-1273 (Moderna COVID-19 Vaccine). The rechallenge was not applicable since only information about the first dose was disclosed. The benefit-risk relationship of mRNA-1273 (Moderna COVID-19 Vaccine) is not affected by this report.; Sender's Comments: This case concerns a 35-year-old, female patient with no previous relevant medical history, who experienced the unexpected event of vaccination site pruritus. The event occurred on the same day after the first dose of mRNA-1273 (Moderna COVID-19 Vaccine). The rechallenge was not applicable since only information about the first dose was disclosed. The benefit-risk relationship of mRNA-1273 (Moderna COVID-19 Vaccine) is not affected by this report.
Within 8 hours of getting the shot, I developed intense arm pain, redness, swelling, hot to touch. Fever, body aches, and muscle pains (especially back) persisted through the night. Tired, weak, lightheaded the next morning. Headache and body aches persisted through the next day. After two days, the arm and injection site was itchy, sore, and red and this lasted three days before gradually resolving.
Tinnitus (severe). Hearing loud pounding noises 24/7. Can't sleep. ENT doctor > Ear exam was normal, hearing test was normal, brain catscan was normal. Tinnitus began on March 30, 2021 and continued with no end in sight. Been suffering for 3 months.
swollen lymph nodes; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (swollen lymph nodes) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (swollen lymph nodes). At the time of the report, LYMPHADENOPATHY (swollen lymph nodes) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment medications were reported.
Severe shoulder pain and became very difficult to move arm. Worse as of 10/19/2015.
After the second vaccine my muscle at injection site is spasming last about ten or twenty minutes has been consistent since second shot.
Not feeling to good; Heavy breathing; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Heavy breathing) and MALAISE (Not feeling to good) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, the patient experienced MALAISE (Not feeling to good). In November 2021, the patient experienced DYSPNOEA (Heavy breathing). At the time of the report, DYSPNOEA (Heavy breathing) had not resolved and MALAISE (Not feeling to good) outcome was unknown.            Relevant concomitant medications were not reported. Treatment information was not provided. Patient had heavy breathing during the call (per agent perception)
flu like symptoms presented 18Aug07, coughing, sneezing, nausea, dizziness, cold chills, aches and pains in the joints. Vaccinated with smallpox on 12Aug07.
The following morning after the injection I woke up with blurry vision. I could see but everything was like if I was not wearing my glasses or contacts when I was. I checked to make sure if it was my contacts but my vision was still blurry with my glasses. I had planned to seek medical help if it was still blurry by the following morning but my vision had returned to normal by evening time (did not note the exact time but around 7).
24 hours after shot, had restricted chest and wheezing, continues unabated 10 weeks later
12/19/21 presents to ED for "Confusion, weakness". PMHx of "COPD, dementia (AOx3), HTN"
Left of my breast, almost in the armpit region, it is swelled up, and a bit tender and sore; Left of my breast, almost in the armpit region, it is swelled up, and a bit tender and sore; Left of my breast, almost in the armpit region, it is swelled up, and a bit tender and sore; This is a spontaneous report from a contactable other HCP reported for himself.  A 52-years-old male patient received second dose of BNT162B2 (BNT162B2, Formulation: solution for injection, Batch/Lot Number: EL9261; Expiration date: Unknown) via intramuscular route of administration, in left arm on 25Jan2021 at 06:45am as single dose for COVID-19 immunization. No Medical history was reported. There were no known allergies to medications, food, or other products. The patient's concomitant medications were not reported. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and other medications within 2 weeks of vaccination. Prior to vaccination, the patient did not diagnose with COVID-19. No other medications the patient received within 2 weeks of vaccination. The patient previously received the first dose of BNT162B2 (solution for injection, Batch/Lot number: unknown) on an unknown date for COVID-19 immunization and experienced no adverse event.   On 27Jan2021, the patient experienced left of my breast, almost in the armpit region, it is swelled up, and a bit tender and sore. It was reported that the events were four days after patient 2nd dose. No treatment was received for the adverse event. The most recent COVID-19 vaccine was administered in hospital. Since the vaccination, the patient has not tested for COVID-19. Events were reported as non-serious. The outcome of the events was not recovered.  Follow-up attempts were completed. No further information was expected.
Pain & swelling at the injection site. "... swelling is about the size of an egg".
Patient had first dose Moderna on 8/30. Returned on 9/27 to administer second dose and patient was mistakenly given a standard dose of Pfizer when he should have received Moderna.
COLD SWEATS, FEVER, DEHYDRATION, WEAK, NO ENERGY, DIARRHEA
Pt received Pfizer vaccines on 02/24/21, 03/17/21 and 10/02/21. Pt presented to the ED on 11/19 with complaints of SOB. Pt was found to have oxygen saturation of 83%, so she was placed on supplemental oxygen. Pt was tested for COVID, which was positive. CXR showed COVID pneumonia with bilateral infiltrates. Pt was discharged home on 11/25/21 with home care.
Dilated left pupil, major headache that I have had since September 25th, low blood pressure, dizzy, passing out
Crohn's disease; is immunocompromised; there was no more data than that in the PI. Limited data due to caller hanging up.; received PNEUMOVAX 23 on 04/2015 and 05/2015; This spontaneous report as received from a patient's mother, refers to a female patient of unknown age. No information regarding the patient's pertinent medical history, concomitant medications, drug reactions and allergies was provided.  On an unknown date in April 2015, the patient was vaccinated with a dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection (dose, route of administration, lot number and expiration date were not reported); on an unknown date in May 2015, she received the next dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection (dose, route of administration, lot number and expiration date were not reported), both as prophylaxis. On unknown dates (it was not stated if it was before or after pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) vaccination), the patient experienced Crohn's disease and immunodeficiency (as it was stated that she was immunocompromised). She was taking a chemo type pill every day for Crohn's disease. The patient's physician wanted to do the re-vaccination. However, the patient's mother wanted to know if that was safe and was upset due to limited data according pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23). The outcome of Crohn's disease and immunodeficiency was determined to be not recovered.  The relatedness between the events and pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) was not provided.  Upon internal review, the events of Crohn's disease and immunodeficiency were determined to be medically significant.
DIAGNOSED BY PHYSICIAN AS CELLULITIS.  SWOLLEN, RED, HOT AREA AT INJECTION SITE.  TREATED WITH CIPRO 250MG FOR 5 DAYS.
Swollen and red injection site, about 7 days after injection and continuing to now, 2/27/2021, 2:35 pm PST.  I guess it is called Covid arm.  I am scheduled for my 2nd vaccine 3/18/2021 and want to know if it is safe.
pt recv vax & pt sought medical attention & a lab eval revealed negative rubella antibodies (0.79);
Headache, Myalgia, Chills, shivering, injection site pain Narrative:
Patient called this morning to report her arm was red and felt warm to the touch.  I recommended for her to get it checked out if it continued to feel warm/if the redness expanded or persisted
This spontaneous report has been received from a nurse practitioner regarding a patient of unknown age and gender. The patient's concurrent condition, medical history and concomitant medications were not reported. On an unknown date, the patient was vaccinated  VARIVAX dose 1, (dose, lot # and expiry date unknown). On 24-APR-2013, the patient received improperly stored VARIVAX dose 2, from lot # 0610AE (dose, vaccination site, route, expiry date unknown). No adverse effects were reported. The reporter stated that inconsistencies in storage temperature were identified on extensive review and records. The reporter stated that vaccine was not thawed. The nurse practitioner reported that there was insufficient data to provide 100 percent assurance on vaccine stability. This is one of the several reports received from the same reporter. Additional information has been requested.
Small amt redness around injection site 2 days post injection. Advised to use ice and take BENADRYL to decrease redness. 2 hours later red spots began to show up in other areas. Advised pt to call Dr immediately or go to ER. Dr called in prednisone.
she started with Sneezing, watery and itchy eyes; she started with Sneezing, watery and itchy eyes; she started with Sneezing, watery and itchy eyes; This is a spontaneous report received from contactable reporter(s) (Consumer or other non-HCP) from medical information team. The reporter is the patient.  A 89 year-old female patient received bnt162b2 (COMIRNATY), administered in arm left, administration date 29Sep2021 10:00 (Lot number: 301458A) at the age of 89 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Diabetic" (ongoing), notes: Verbatim: Diabetic, Diagnosed: between 15-20 years ago. Family history included: "Allergies" (unspecified if ongoing), notes: Family Medical History Relevant to AE(s): her daughter has allergies. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose Number: 1, LOT: EL9263, Route: Right arm, Manufacturer: Pfizer), administration date: 27Jan2021, for Covid-19 Immunization; Bnt162b2 (Dose Number: 2, Route: Right arm), administration date: 16Feb2021, for Covid-19 Immunization. The following information was reported: EYE PRURITUS (non-serious), LACRIMATION INCREASED (non-serious) all with onset 03Oct2021, outcome "recovering" and all described as "she started with Sneezing, watery and itchy eyes"; SNEEZING (non-serious) with onset Oct2021, outcome "recovering".  Additional information: Caller states she received the Pfizer COIVD-19 booster dose and about a week later she started with Sneezing, watery and itchy eyes, feels fines otherwise.  She states she never had allergies before in her life and she did not start any new medications or change anything else. She is wondering if these symptoms could be from the vaccine. She does not feel like she has a cold and has no other symptoms. Additional vaccines administered on same date of the pfizer suspect reported as none. Event does not require to visit emergency room or physicians office. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.  Follow-up attempts are completed. No further information is expected.
Induration and erythema 2.5 by 2 inches, concomitant Otitis Media.
24 hrs after administration of DTaP number 5 developed left leg discomfort and swelling to below knee
The patient reported that after receiving the PNEUMOVAX vaccine, he experienced severe swelling in his left arm. There wasn't any itching, but he was in pain.
pt presented to ER 27NOV96 APAP x2 w/inability to move upper &  lower extremities;20NOV fever, parents noticed that pt had pain in back when lifted;progress to inability to move extremities, weak cry, emesis;
Client reported numbness and burning sensation to lips 10 minutes after vaccination.  Evaluated by EMS on site.  No medical intervention initiated.  Client observed for 40 minutes.  Client reported decreased numbness and burning.  Awake, alert, verbally responsive.  Client released by EMS.  No distress noted.
Pt was vaccinated in 1997. Pt was exposed to varicella on approximately 10/14/1999. On 10/27/1999 pt experienced fever and malaise. On 10/28/1999 pt developed chickenpox. Pts sibling had a similar experience after exposure to varicella.
This spontaneous report as received from a consumer via Clinic refers to a currently 5 year old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 11-AUG-2017, the patient was vaccinated with improperly stored dose of M-M-R II, recombinant human albumin (rHA) 1 dose unit (lot # M020073, Expiry date was not reported) for prophylaxis (product storage error). There were no previous temperature excursions recorded. It was unknown if data logger was involved. No adverse effects were reported. There was no product quality complaint involved. This is one of the several reports received from the same reporter.; Sender's Comments: US-009507513-1801USA000166:
Stomach pain; body aches; chills; fever; headache; joint pain; This is a spontaneous report from a contactable healthcare professional (patient). A 58-years-old non pregnant female patient received first dose of bnt162b2 (BNT162B2, solution for injection, Batch/Lot Number: EN6203) administered in left arm via an unknown route of administration (at the age of 58 years old) on 25Feb2021 at 14:15 pm as dose 1, single for covid-19 immunisation. Medical history included chronic sinusitis (event verbatim-Chronic sinusitis, pneumonia). Other concomitant medications in two weeks included allergy injections. The patient had known allergies to Penicillin and other antibiotics. It was reported that the patient did not have covid prior vaccination. The patient did not tested covid post vaccination. On 26Feb2021 at 14:00pm, the patient experienced stomach pain, body aches, chills, fever, headache and joint pain.  No treatment was received for all the events. The outcome of all the events was reported as recovering. No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
Information has been received from a physician concerning a 68 year old female who in 1989 was vaccinated with 1 dose of pneumococcal vaccine 23 polyvalent. In 1989, the pt experienced an injection site reaction described as a red, swollen, painful area at the injection site. Additional information has been requested.
He got his vaccine, he was fine.  About few hours later he had fever, fatigue, headache and then coughing, which is what he had with the rest of the vaccines.  The only difference this time he had pain with urinating, 40 hours and redness.  He has never had that with the other vaccines.  He took Tylenol for his headaches.  He started to have less and less pain and within 40 hours it was completely gone.  He checked the internet and did not see that AE listed.  He did not call his doctor and just wanted to wait about 48 hours and see if it resolved.
17 patients administered expired Moderna Covid-19 vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (17 patients administered expired Moderna Covid-19 vaccine) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (17 patients administered expired Moderna Covid-19 vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (17 patients administered expired Moderna Covid-19 vaccine) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant products were reported.  On 14-SEP-2021, the vial was initially stored in the refrigerator and administered on same day.  Vial didn't undergo any temperature excursions. It was unknown in which arm the patient received the Moderna Covid-19 vaccine. The patient did not report any adverse events.  No treatment information was reported.
he was diagnosed to have COVID-19; he was diagnosed to have COVID-19; This is a spontaneous report from a contactable other HCP (patient) reported for himself via medical information team. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 03Aug2021 (Batch/Lot number was not reported) as dose 1, single for covid-19 immunisation. The patient was unable to get his second dose (scheduled originally on 24Aug2021) due to reasons not health related. The patient medical history and concomitant medications were not reported. In that coming weekend in Aug2021 the patient was diagnosed covid-19 and was currently roughly 17 days out.  The lot number for BNT162b2 was not provided and will be requested during follow up.; Sender's Comments: Based on the information in the case report, a possible causal relationship between reported event Covid 19 and suspect drug BNT162B2 cannot be completely excluded.
2 days after this vaccine I delevoped severe pain in my upper back teeth, my lower back teeth and my cheek and far back of mouth on the left side. It  was almost unbearable. I was already taking diclofenac for an orthopedic problem, i added 1000m tylenol to that every 4 hours, i put a heating pad on my face, I rubbed some old expired betamethasone ointment on my face, I took some flexeril that I had. On the 4th day post vaccine it is much better, only taking diclofenac now. I don't see how this was a dental pain, I couldn't pinpoint it to a  specific tooth. Since it is getting better I have delayed going to the dentist plus I'm not even sure it is a dental problem.
Began with a fever that night, 102.4, fever and chills, achiness and headache. Took 2 motrin tablets. In the morning still running 100.6 with the same symptoms.
Quarter size red hard flat lump day after vaccine. 48 hours after appearance it was softer, but 3 times the size and hot to the touch. The lump never grew, only the redness grew.
RIGHT BELLS PALSY ACUTE STROKE, UNSPECIFIED TYPE AND ARTERY 4/26/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS